Market Tracker

05/29 7:56am ET

Actavis PLC (NYSE:ACT)

313.08
Delayed Data
As of May 28
 +6.29 / +2.05%
Today’s Change
201.91
Today|||52-Week Range
317.72
+21.63%
Year-to-Date

Today’s Trading

Previous close306.79
Today’s open308.46
Day’s range-- - --
Volume3,943,837
Average volume (3 months)2,998,413
Market cap$120.5B
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.45%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.40-0.70%
BMYBristol-Myers Squibb+0.75+1.10%
GSKGlaxoSmithKline+0.18+0.40%
SNYSanofi-0.14-0.28%
Data as of 05/28/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$4.36
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts